(Q42217719)

18 October 2017

Antibodies to Epstein-Barr virus and MRI disease activity in multiple sclerosis (English)

1 reference

18 October 2017

0 references

0 references

1 reference

3

Trygve Holmøy

1 reference

18 October 2017

2

Kjell-Morten Myhr

1 reference

18 October 2017

15

Oivind Torkildsen

1 reference

18 October 2017

10

Rune Midgard

1 reference

18 October 2017

14

Stig Wergeland

1 reference

18 October 2017

Silje Kvistad

1

1 reference

18 October 2017

Søren Bakke

4

1 reference

18 October 2017

Antonie G Beiske

5

1 reference

18 October 2017

Kristian S Bjerve

6

1 reference

18 October 2017

Harald Hovdal

7

1 reference

18 October 2017

Kristin I Løken-Amsrud

8

1 reference

18 October 2017

Finn Lilleås

9

1 reference

18 October 2017

Gro Njølstad

11

1 reference

18 October 2017

Tom Pedersen

12

1 reference

18 October 2017

Jūratė Šaltytė Benth

13

1 reference

18 October 2017

19 May 2014

1 reference

Multiple Sclerosis Journal

18 October 2017

1 reference

18 October 2017

20

1 reference

18 October 2017

14

1 reference

18 October 2017

1833-1840

1 reference

https://api.crossref.org/works/10.1177%2F1352458514533843

18 October 2017

1 reference

The initiation and prevention of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514533843

Risk factors in the development of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514533843

Epstein-Barr virus cause of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514533843

Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514533843

Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514533843

The risk of developing multiple sclerosis in individuals seronegative for Epstein-Barr virus: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514533843

Are there Epstein-Barr virus seronegative patients with multiple sclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514533843

Association between clinical disease activity and Epstein-Barr virus reactivation in MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514533843

Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514533843

Epstein-Barr virus and disease activity in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514533843

ω-3 fatty acid treatment in multiple sclerosis (OFAMS Study): a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514533843

Comparison of two commercial ELISA systems for evaluating anti-EBNA1 IgG titers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514533843

Epstein-Barr virus antibodies and vitamin D in prospective multiple sclerosis biobank samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514533843

Inflammation markers in multiple sclerosis: CXCL16 reflects and may also predict disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514533843

Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514533843

Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514533843

Antibodies to specific EBNA-1 domains and HLA DRB1*1501 interact as risk factors for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514533843

Epstein-Barr virus and multiple sclerosis: interaction with HLA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514533843

Altered prevalence and reactivity of anti-Epstein-Barr virus antibodies in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514533843

Altered antibody pattern to Epstein-Barr virus but not to other herpesviruses in multiple sclerosis: a population based case-control study from western Norway

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514533843

Epstein-Barr virus in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514533843

Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514533843

Serum concentration of immunoglobulin G-type antibodies against the whole Epstein-Barr nuclear antigen 1 and its aa35-58 or aa398-404 fragments in the sera of patients with systemic lupus erythematosus and multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514533843

Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514533843

An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514533843

Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514533843

Measurement of EBV-IgG anti-VCA avidity aids the early and reliable diagnosis of primary EBV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514533843

Assessment of Epstein-Barr virus in blood from patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458514533843

21 January 2018

Identifiers

DOI

10.1177/1352458514533843

1 reference

18 October 2017

1 reference